Aytu Biopharma, Inc.
AYTU
$2.17
-$0.04-1.81%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/28/2025
-
GuruFocus
10/28/2025
-
GuruFocus
10/28/2025
-
The Fly
10/28/2025
-
ACCESS Newswire
10/13/2025
-
Zacks Investment Research
10/10/2025
-
GuruFocus
10/10/2025
-
ACCESS Newswire
10/8/2025
-
ETF Channel
10/8/2025
-
The Fly
10/1/2025
-
The Fly
9/25/2025
-
GuruFocus
9/25/2025
-
The Fly
9/25/2025
-
Insider Monkey
9/25/2025
-
ACCESS Newswire
9/25/2025
-
Simply Wall St
9/25/2025
-
GuruFocus
9/24/2025
-
ACCESS Newswire
9/24/2025
-
The Fly
9/24/2025
-
GuruFocus
9/24/2025
-
GuruFocus
9/24/2025
-
GuruFocus
9/24/2025
-
SeekingAlpha
9/24/2025
-
Seeking Alpha: Transcripts
9/24/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, September 23, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
720 437 6580
Address
Denver Corporate Center III
Suite 920 - 7900 East Union Avenue
Denver, CO 80237
Suite 920 - 7900 East Union Avenue
Denver, CO 80237
Country
Year Founded
--
Business Description
Sector
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment...
more